Baird’s Integra LifeSciences IART Stock Holding History

Baird’s Portfolio IART Stock Details IART Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q3	–	Sell	-10,826	Closed	-$208K	–	1131
2014 Q2	$208K	Sell	10,826 -14,030	-56%	-$261K	﹤0.01%	1087
2014 Q1	$467K	Buy	24,856 +800	+3%	+$15.4K	0.01%	876
2013 Q4	$469K	Buy	24,056 +154	+0.6%	+$2.83K	0.01%	859
2013 Q3	$393K	Sell	23,902 -240	-1%	-$3.85K	0.01%	871
2013 Q2	$361K	Buy	+24,142	New	+$354K	0.01%	865

Other funds holding IART

ACM

Americafirst Capital Management Roseville, California $74M AUM 13.49% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VNIM

Vaughan Nelson Investment Management Houston, Texas $11.3B AUM 53% 1-Year Est. Return

CIP

Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return

EIP

Epoch Investment Partners New York $16.5B AUM 24.3% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Baird's IART Position: Q3 2014 in Review

Baird sold out of Integra LifeSciences (IART) in Q3 2014, closing a stake of 10,826 shares — an estimated $208K sold.

Baird first reported a position in IART in Q2 2013 and held it in 5 quarters. The position peaked at $469K in Q4 2013. 143 funds tracked by Wall St. Rank hold IART as of Q3 2014.

Baird reported no remaining Integra LifeSciences position as of Q3 2014 after selling out during the quarter.
Baird sold 10,826 Integra LifeSciences shares in Q3 2014, an estimated $208K.
Baird first reported a position in Integra LifeSciences in Q2 2013 and held it in 5 quarters.
Baird's Integra LifeSciences position peaked at $469K in Q4 2013.
143 funds tracked by Wall St. Rank held Integra LifeSciences as of Q3 2014.

Based on Baird's 13F filing for Q3 2014, filed 12 Nov 2014.